INS and type 1 diabetes mellitus: In this third phase of type 1 diabetes, the nutritional intake supporting insulin therapy leads patients from ketoacidosis to euglycemia and often reduces their insulin needs, introducing them to the honeymoon phase (conventionally referred to as a reduced insulin demand of <0.5 IU/kg/day, sharing a glycosylated hemoglobin percentage (HbA1c%), <7) and preserving residual β-cell endogen function.